Medifast (NYSE: MED) president lists stock options and RSUs

Rhea-AI Filing Summary

Medifast president Nicholas Mark Johnson filed an initial insider report detailing his existing equity stake. He holds stock options covering 22,640 shares of common stock at an exercise price of $66.68 expiring in 2028, direct ownership of 18,776 common shares, and several restricted stock unit awards that each represent a right to receive one share of common stock and vest in three equal annual installments beginning on March 13, 2024, March 25, 2025, and March 25, 2026.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Johnson Nicholas Mark

Role President

Type	Security	Shares	Price	Value
holding	Stock Options	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock (Restricted Stock Unit)	--	--	--
holding	Common Stock (Restricted Stock Unit)	--	--	--
holding	Common Stock (Restricted Stock Unit)	--	--	--

Holdings After Transaction: Stock Options — 22,640 shares (Direct); Common Stock — 18,776 shares (Direct); Common Stock (Restricted Stock Unit) — 2,428 shares (Direct)

Footnotes (1)

1. Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date, March 13, 2024. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date, March 25, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date, March 25, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Johnson Nicholas Mark

(Last) (First) (Middle)

C/O MEDIFAST, INC.

1501 S. CLINTON STREET, SUITE 500

(Street)

BALTIMORE MARYLAND 21224

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
01/05/2026

3. Issuer Name and Ticker or Trading Symbol
MEDIFAST INC [ MED ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	18,776	D
Common Stock (Restricted Stock Unit)	2,428(1)	D
Common Stock (Restricted Stock Unit)	13,457(2)	D
Common Stock (Restricted Stock Unit)	34,906(3)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	02/07/2023	02/07/2028	Common Stock	22,640	$66.68	D

Explanation of Responses:

1. Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date, March 13, 2024. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

2. Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date, March 25, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

3. Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date, March 25, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

Exhibit List: Exhibit 24 - Limited Power of Attorney.

	/s/ Jason L. Groves, attorney-in-fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Medifast (MED) Form 3 filing by Nicholas Mark Johnson show?

The Form 3 shows Medifast president Nicholas Mark Johnson’s existing equity stake, including common stock, stock options, and restricted stock units. It is an initial ownership report, not a record of new share purchases or sales.

How many Medifast (MED) shares are covered by Nicholas Mark Johnson’s stock options?

Nicholas Mark Johnson holds stock options over 22,640 shares of Medifast common stock. These options have an exercise price of $66.68 per share and expire on February 7, 2028, providing long-dated potential equity exposure.

What Medifast (MED) common stock does Nicholas Mark Johnson directly own?

Nicholas Mark Johnson directly owns 18,776 shares of Medifast common stock. This reflects his current direct shareholding as reported, separate from any stock options or restricted stock unit awards disclosed in the filing.

How are Medifast (MED) restricted stock units for Nicholas Mark Johnson structured?

His Medifast restricted stock units were issued under the 2012 Share Incentive Plan and vest in three equal annual installments. Vesting for these grants begins on March 13, 2024, March 25, 2025, and March 25, 2026, respectively, subject to plan terms.

Do Medifast (MED) restricted stock units give immediate shares to Nicholas Mark Johnson?

No, each restricted stock unit represents a contingent right to receive one Medifast common share. Shares are delivered only as the units vest over three equal annual installments under the 2012 Share Incentive Plan.